Branch² Intelligence

OpenAI, Anthropic likely to face a cash-flow wall in 2027: Brookings decode why Wall Street expects AI spending to slow

IN · 2026-10-08

India — direction and magnitude withheld

Direction and magnitude are withheld for India-region stories. Named companies below are shown without any directional call or impact magnitude; the omission is deliberate, not missing data. This intelligence is provided for informational purposes only. Branch² is not a SEBI-registered research analyst. This is not investment advice. Past performance is not indicative of future results. Please consult a SEBI-registered investment adviser before making any investment decision. Users must comply with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Key takeaway

A Brookings paper by Columbia professor Stijn Van Nieuwerburgh warns that frontier AI firms (OpenAI, Anthropic) face a cash-flow crunch by 2027 as hyperscaler capex exceeds combined Big Tech operating cash flows

  1. Step 1 · The triggera Brookings paper projects hyperscaler AI capex will exceed combined Big Tech operating cash flows in 2026, straining the funding model for frontier AI labs
  2. Step 2 · Knock-onhyperscalers face pressure to rationalise AI infrastructure spend, slowing GPU and custom silicon orders
  3. Step 3 · Knock-onNVIDIA, AMD, Broadcom, Marvell see data centre revenue growth decelerate as their largest customers cut orders
  4. Step 4 · Knock-onIT services firms and cloud migration partners in India face project delays and pricing pressure as hyperscaler demand softens
  5. Step 5 · Reaches youIndian SMEs dependent on AI services revenue or hyperscaler credits face contract renegotiation risk and demand uncertainty

The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.

Source: livemint.com

See what today’s news does to your business. Atri by Branch² — Early-warning intelligence for your business

This is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.